Resection of stage III non-small cell lu
✍
Valerie W. Rusch
📂
Article
📅
1995
🏛
Springer
🌐
English
⚖ 779 KB
Approximately 25%-30% of all patients with non-small cell lung cancer (NSCLC) present with stage III tumors. Except for specific subsets, these tumors are not usually amenable to complete surgical resection and are associated with a 5-year survival of 10% or less. Because patients with stage III NSC